The vetoed bill would have required insurers to treat people with epilepsy like other enrollees and cover certain prescribed nerve stimulation devices.
The vetoed bill would have required individual and group health plans to give people with epilepsy the same coverage and benefits as people without epilepsy.
The vetoed bill would have barred insurers from ending or refusing to renew a person's health coverage solely because the person has epilepsy.
The vetoed bill would have required individual and group health plans to cover medically necessary nerve stimulation devices prescribed by a licensed doctor actively treating the patient.
The vetoed bill would have required insurers to give people diagnosed with epilepsy the same coverage and benefits as people without that diagnosis. This would apply to individual and group health policies that cover medical and surgical care. The bill proposed an effective date of November 1, 2026, if enacted.
The vetoed bill would have barred insurers from ending or refusing to renew a person's health coverage solely because of an epilepsy diagnosis. This would apply to an individual's health insurance coverage. The diagnosis must be the sole reason for ending or refusing to renew coverage. The bill proposed an effective date of November 1, 2026, if enacted.
The vetoed bill would have required covered health plans to cover medically necessary nerve stimulation devices prescribed by a licensed doctor actively treating the enrollee. This would apply to individual and group health policies that cover medical and surgical care. The device must be medically necessary and prescribed by a licensed doctor actively treating the enrollee. The bill proposed an effective date of November 1, 2026, if enacted.
No hearings or votes scheduled.